KYMERA THERAPEUTICS, INC. — Income Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+55.5% +$12M
$34M
Cost of Revenue↑+55.5% +$12M
$34M
R&D↑+22.3% +$18M
$98M
D&A↓-1.3% -$26K
$2M
Operating Income↓-13.1% -$10M
$-84M
EBITDA↓-13.5% -$10M
$-82M
Tax Provision
$100K
Net Income↓-5.6% -$4M
$-69M
Operating Margin↑+91.9pts
-244.9%
Net Margin↑+95.3pts
-201.5%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-7.9pts
0.0%
Operating Lease Cost↓-1.8% -$44K
$2M
Revenue YoY Variation↓-59.3pts
55.5%
Income YoY Variation↑+15.6pts
-13.1%
Revenue QoQ Variation↑+898.5pts
1097.4%
Income QoQ Variation↑+32.2pts
-9.4%